India Pesticides
- Market cap
- ₹ 1,331 Cr.
- P/E
- 12.4x
- P/B
- 1.36x
- 52-week range
- 111.01 – 196.93
- ROE
- 13%
- ROCE
- 17%
- Dividend yield
- 0.6%
- Debt / equity
- 0.11
- Sector
- Fertilizers & Agrochemicals
- Industry
- Pesticides & Agrochemicals
- Listed on
- NSE, BSE
About
India Pesticides Limited is an India-based globally operating agrochemical company, which manufactures Agro-Chemicals and Active Pharma Ingredients (APIs). The Company offers herbicides, fungicides, insecticides, growth regulators, intermediates, acaricide, and APIs. Its product categories include Technicals, Formulations, and APIs. Its Technicals products include Prosulfocarb, Pretilachlor, Cymoxanil, Captan, Folpet, Diafenthiuron, Thiamethoxam, Thiocarbamate, Pyriproxyfen, Etridiazole and Phosphoro Ethyl Di‑Amide (PEDA). Its branded formulations include Grip, Pendizet, Trisol, Clogold, Vecto, Trim, Sodhit, Captax-50, Carbo, Tridev, Difen, Star, Talvar, Contanol, Guru, Shakti, and Sparkle. Its API products are used for manufacturing final drugs to treat dermatological problems, such as antifungal and anti-scabies medications. It has its manufacturing site for agrochemical production at Sandila and Dewa Road in Uttar Pradesh.
Quick check
The five things to look at first. Open one for more.
Compared with its industry
Pesticides & Agrochemicals: 33 companies →India Pesticides against the typical company in its industry. The rank is out of the companies that report each figure; green means the better quarter of the pack, red the worse quarter.
- Valuation (P/E)12.4 against a typical 23.3: cheaper than most peers (1st = cheapest).8th of 33
- Sales growth−8.4% against a typical −4.5% from a year earlier.18th of 31
- Profit growth−34.3% against a typical +15.2% from a year earlier.20th of 25
- Share price, 3 months−23.8% against a typical −15.7%.22nd of 32
- Size₹ 1,330.6 Cr. market value against a typical ₹ 883.3 Cr. (1st = largest).14th of 31
Credit ratings
Every rating action on file, newest first, including reaffirmations. Open a row for the agency's reasoning. All credit rating updates
Adequate safety
Rated A+ by CARE- No warnings from the agency.
| Agency | Current rating | Outlook | As of |
|---|---|---|---|
| CARE | CARE A+ / CARE A1+ | Stable | 22 Sep 2026 |
| Rating | Details | |||||
|---|---|---|---|---|---|---|
| 22 Sep 2026 | Reaffirmed | CARE A+ / CARE A1+ | — | CARE | ₹ 180 Cr. | |
| 9 Oct 2025 | Reaffirmed | CARE A+ / CARE A1+ | — | CARE | ₹ 160 Cr. |
Board meetings
Results dates and other board meetings. Full calendar
| Details | ||
|---|---|---|
| 3 Nov 2026Upcoming | Financial Results | To consider and approve the financial results for the period ended September 30, 2026 |
| 1 Aug 2026 | Financial Results | To consider and approve the financial results for the period ended Jun 30, 2026 |
| 23 May 2026 | Financial Results/Dividend | To consider and approve the financial results for the period ended March 31, 2026 and dividend |
| 9 Feb 2026 | Financial Results | To consider and approve the financial results for the period ended December 31, 2025 |
| 11 Nov 2025 | Financial Results | To consider and approve the financial results for the period ended September 30, 2025 |
| 7 Aug 2025 | Financial Results | To consider and approve the financial results for the period ended Jun 30, 2025 |
| 26 May 2025 | Financial Results/Dividend | To consider and approve the financial results for the period ended March 31, 2025 and dividend |
Financials
Consolidated figures in ₹ crore.
| ₹ Cr. | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 202 | 151 | 126 | 220 | 229 | 172 | 207 | 275 | 290 | 225 | 266 | 252 |
| Expenses | 175 | 118 | 122 | 192 | 195 | 146 | 176 | 230 | 242 | 188 | 225 | 216 |
| Operating Profit | 27 | 33 | 4 | 28 | 34 | 27 | 32 | 45 | 49 | 38 | 42 | 35 |
| OPM % | 13% | 22% | 3% | 13% | 15% | 15% | 15% | 16% | 17% | 17% | 16% | 14% |
| Other Income | 4 | 4 | 4 | 4 | 5 | 3 | 3 | 9 | 5 | 3 | 4 | 4 |
| Interest | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 3 | 3 |
| Depreciation | 4 | 4 | 4 | 4 | 4 | 5 | 5 | 5 | 5 | 6 | 5 | 6 |
| Profit before tax | 27 | 32 | 2 | 27 | 34 | 23 | 29 | 47 | 47 | 34 | 38 | 31 |
| Tax % | 26% | 26% | 47% | 27% | 23% | 31% | 25% | 26% | 33% | 33% | 19% | 26% |
| Net Profit | 20 | 24 | 1 | 19 | 26 | 16 | 22 | 35 | 32 | 23 | 31 | 23 |
| EPS in Rs | 1.69 | 2.08 | 0.09 | 1.69 | 2.25 | 1.4 | 1.89 | 3.03 | 2.74 | 1.97 | 2.66 | 1.97 |
Growth and returns
Compounded yearly rates over each period.
- 10 Years
- —
- 5 Years
- 10%
- 3 Years
- 6%
- TTM
- 17%
- 10 Years
- —
- 5 Years
- −2%
- 3 Years
- −6%
- TTM
- 9%
- 10 Years
- —
- 5 Years
- −15%
- 3 Years
- −14%
- TTM
- —
- 10 Years
- —
- 5 Years
- 15%
- 3 Years
- 10%
- TTM
- —
P/E and EPS over time
Daily P/E and trailing 12-month EPS. EPS updates with each result.
Peers
Listed companies in the same business.
| India Pesticides | ₹ 116.00 | ₹ 1,331 Cr. | 12.4x | 1.4x | 13% | — |
| Asian Paints | ₹ 2,305.00 | ₹ 2,21,095 Cr. | 58.1x | 12.1x | 21.2% | 12.4% |
| Pidilite Industries | ₹ 1,514.00 | ₹ 1,54,107 Cr. | 64.8x | 14.7x | 23.8% | 16.9% |
| Solar Industries India | ₹ 18,320.00 | ₹ 1,65,778 Cr. | 102.6x | 27.4x | 31.4% | 17.7% |
| SRF | ₹ 2,309.00 | ₹ 68,444 Cr. | 44.5x | 6.1x | 13.8% | 11.6% |
| Linde India | ₹ 5,697.00 | ₹ 48,586 Cr. | 108.7x | 14x | 13.6% | 21.7% |
Management
- Dheeraj Kumar Jain
- Chief Executive Officer
- Satya Prakash Gupta
- Chief Financial Officer
- Kuruba Adeppa
- Whole Time Director
- Udaya Bhaskar Mantripragada
- Additional Whole-Time Director
Prices are delayed and for information only. Nothing on this page is investment advice.